Why the study?
Therapy in elderly patients with isolated systolic hypertension is motivated by their 2–4 times increased risk of myocardial infarction, left ventricular hypertrophy, chronic kidney disease, stroke, and cardiovascular mortality.
Observational (n=37)
No
Answers are grounded in this paper and cite their sources.
Clinical review demonstrates elevated cardiovascular and organ damage risks in elderly isolated systolic hypertension, highlighting the necessity of amlodipine intervention.
Основанием для проведения терапии у пациентов пожилого возраста с ИСГ служит факт возрастания в 2–4 раза риска развития инфаркта миокарда, гипертрофии левого желудочка, хронической почечной недостаточности, инсульта, и смертности в результате сердечно-сосудистых заболеваний.
No takes yet. Share an insight, caveat, or question.
o’g’li et al. (2025) conducted an observational in Isolated systolic hypertension (n=37). Amlodipine vs. Baseline (no control group) was evaluated on Achievement of target systolic blood pressure (<140 mm Hg) (p=<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: